Zobrazeno 1 - 10
of 50 309
pro vyhledávání: '"Acute lymphoblastic leukemia"'
Autor:
Kopmar NE, Cassaday RD
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 1587-1596 (2024)
Noam E Kopmar,1,2 Ryan D Cassaday1,2 1Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA; 2Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USACorresponden
Externí odkaz:
https://doaj.org/article/39b645b6b6ba4b0183e72281f86633ab
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-36 (2024)
Abstract The application of chimeric antigen receptor T-cell therapy in central nervous system tumors has significantly advanced; however, challenges pertaining to the blood-brain barrier, immunosuppressive microenvironment, and antigenic heterogenei
Externí odkaz:
https://doaj.org/article/60954a8e09d34cf2a8244022f988b5b1
Autor:
Vasiliki Karpa, Kallirhoe Kalinderi, Eleni Gavriilaki, Vasiliki Antari, Emmanuil Hatzipantelis, Theodora Katopodi, Liana Fidani, Athanasios Tragiannidis
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 10, Pp 11537-11547 (2024)
Methotrexate (MTX) is an anti-folate chemotherapeutic agent that is considered to be a gold standard in Acute Lymphoblastic Leukemia (ALL) therapy. Nevertheless, toxicities induced mainly due to high doses of MTX are still a challenge for clinical pr
Externí odkaz:
https://doaj.org/article/1ba00bfa0f4d40a380ed34023b7d3622
Autor:
Rustu Oguz, Hayriye Senturk Ciftci, Muge Gokce, Yeliz Ogret, Sedat Karadeniz, Sacide Pehlivan, Kursat Ozdilli, Zeynep Karakas, Serap Karaman, Filiz Aydın
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 4, Pp 327-334 (2024)
Introduction: Epidemiologic studies on pediatric acute lymphoblastic leukemias (ALL) have been conducted to evaluate the possible risk factors including genetic, infectious and environmental factors with the objective of idenfying the etiology. Manno
Externí odkaz:
https://doaj.org/article/b1176e35743548c0b020e195cf7ef689
Autor:
Diana Anaya, Sandra Paola Santander González, Natalia Murillo, Ricardo Ballesteros-Ramírez, Iliana De los Reyes, María V. Herrera, Julio Solano, Susana Fiorentino, Sandra Quijano
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 4, Pp 374-380 (2024)
Introduction: Regulatory T cells (Treg cells) in a tumor environment and the expression of forkhead box P3 (FOXP3) in tumor cells have been associated with a poor prognosis. There are few studies evaluating Treg cells and FOXP3 in B-cell acute lympho
Externí odkaz:
https://doaj.org/article/63b0d10e8fb144f7a522b6afc8e7a183
Autor:
T. S. Chudnova, E. N. Misyurina, E. A. Baryakh, T. N. Tolstykh, L. T. Shimanovskaya, D. E. Gagloeva, E. I. Zhelnova, A. B. Makeshova, K. V. Yatskov, E. N. Zotina, D. D. Ivanova, M. A. Mingalimov, O. L. Kochneva, E. Yu. Grishina, V. N. Yakimets
Publikováno v:
Онкогематология, Vol 19, Iss 3, Pp 206-214 (2024)
Background. Patients with acute lymphoblastic leukemia (ALL) have been the most vulnerable group of patients at risk of severe and extremely severe COVID-19 throughout the coronavirus pandemic. Secondary immunodeficiency due to acute leukemia, as wel
Externí odkaz:
https://doaj.org/article/84e5c35a50cc4b5eade5ae9d63731241
Autor:
Zahra Mehrbakhsh, Roghayyeh Hassanzadeh, Nasser Behnampour, Leili Tapak, Ziba Zarrin, Salman Khazaei, Irina Dinu
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-16 (2024)
Abstract Background Predicting mortality and relapse in children with acute lymphoblastic leukemia (ALL) is crucial for effective treatment and follow-up management. ALL is a common and deadly childhood cancer that often relapses after remission. In
Externí odkaz:
https://doaj.org/article/bf660aa46c644d80884a69c79126ee71
Autor:
Flávia Melo Cunha de Pinho Pessoa, Marcelo Braga de Oliveira, Igor Valentim Barreto, Anna Karolyna da Costa Machado, Deivide Sousa de Oliveira, Rodrigo Monteiro Ribeiro, Jaira Costa Medeiros, Aurélia da Rocha Maciel, Fabiana Aguiar Carneiro Silva, Lívia Andrade Gurgel, Kaira Mara Cordeiro de Albuquerque, Germison Silva Lopes, Ricardo Parente Garcia Vieira, Jussara Alencar Arraes, Meton Soares de Alencar Filho, André Salim Khayat, Maria Elisabete Amaral de Moraes, Manoel Odorico de Moraes Filho, Caroline Aquino Moreira-Nunes
Publikováno v:
DNA, Vol 4, Iss 3, Pp 285-299 (2024)
The detection of genetic alterations in patients with acute leukemias is essential for the targeting of more specific and effective therapies. Therefore, the aim of this study was to compare the sensitivity of Nested-PCR and RT-qPCR techniques in the
Externí odkaz:
https://doaj.org/article/8a444e94819c4c8980b552446fa53025
Acute lymphoblastic leukemia with nephrogenic diabetes insipidus as the first symptom: a case report
Autor:
Ning Qu, Hongtao Zhu
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-7 (2024)
Abstract Background Acute lymphoblastic leukemia is the most common pediatric malignancy, characterized by fever, anemia, hemorrhage, and symptoms brought on by blasts infiltrating organs. Case presentation This is a case report of a 9-year-old Asian
Externí odkaz:
https://doaj.org/article/a7038e4b2d124ac2858bb7fa3f58cc21
Autor:
Jing Lu, Huiying Qiu, Ying Wang, Xin Zhou, Haiping Dai, Xuzhang Lu, Xiaofei Yang, Bin Gu, Ming Hong, Miao Miao, Ruinan Lu, Jun Wang, Qian Wu, Mengxing Xue, Yun Wang, Ailing Deng, Yaoyao Shen, Yin Liu, Xueqing Dou, Yutian Lei, Depei Wu, Yu Zhu, Suning Chen
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-5 (2024)
Abstract Blinatumomab has emerged as a promising component of first-line therapy for acute B-cell precursor lymphoblastic leukemia (BCP-ALL), bolstering treatment efficacy. To mitigate CD19 selection pressure and reduce the incidence of blinatumomab-
Externí odkaz:
https://doaj.org/article/86618ecde62b4bd2b7a24b4410fdab60